CAV protocol FDA Link

chemotherapy protocol consisting of cyclophosphamide, adriamycin, vincristine; CAV refers to first source; acronym ACV refers to second source; acronym ACO II was used in Klin Wochenschr 1982;60(16):829; acronym ACO was used in Onkology 1982;5(4):174; acronym DVC was used in Gan To Kagaku Ryoho 1984;11(4):888

Also Known As:

CHO; ACO; AVC; DVC; ACO II; CADO protocol; NCI PB 93-C-125 protocol; NHL-15 protocol; VAC regimen; VDC regimen

-

Therapeutics: 6127

-

Drug Therapy: 124082

-

Combination Drug Therapy: 8615

-

Antineoplastic Combined Chemotherapy Protocols: 18

*

CAV protocol: 1613

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 18

*

CAV protocol: 1613

-

Clinical Protocols

-

Antineoplastic Protocols: 20

-

Antineoplastic Combined Chemotherapy Protocols: 18

*

CAV protocol: 1613

-

Organic Chemicals: 42

-

Hydrocarbons: 362

-

Halogenated Hydrocarbons: 31

-

Mustard Compounds: 3

-

Nitrogen Mustard Compounds: 1

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 15509

*

CAV protocol: 1613

-

Cyclic Hydrocarbons: 3

-

Aromatic Hydrocarbons: 121

-

Aromatic Polycyclic Hydrocarbons: 617

-

Naphthacenes

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

CAV protocol: 1613

-

Organophosphorus Compounds: 131

-

Phosphoramide Mustards: 3

-

Cyclophosphamide: 15509

*

CAV protocol: 1613

-

Polycyclic Compounds: 59

-

Aromatic Polycyclic Hydrocarbons: 617

-

Naphthacenes

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

CAV protocol: 1613

-

Carbohydrates: 2945

-

Glycosides: 357

-

Aminoglycosides: 1129

-

Anthracyclines: 1388

-

Daunorubicin: 1771

-

Doxorubicin: 15671

*

CAV protocol: 1613

-

Heterocyclic Compounds: 25

-

Alkaloids: 691

-

Indole Alkaloids: 23

-

Secologanin Tryptamine Alkaloids: 49

-

Vinca Alkaloids: 290

-

Vincristine: 5794

*

CAV protocol: 1613

-

2-Ring Heterocyclic Compounds

-

Indoles: 70

-

Indole Alkaloids: 23

-

Secologanin Tryptamine Alkaloids: 49

-

Vinca Alkaloids: 290

-

Vincristine: 5794

*

CAV protocol: 1613

Jacek Pajak Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)